CN EN

Меню

Array ( [0] => Array ( [ID] => 1350 [~ID] => 1350 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Изучение клинико-патогенетических эффектов противовирусного препарата на основе фавипиравира у коморбидных пациентов с COVID-19 на амбулаторном этапе лечения [~NAME] => Изучение клинико-патогенетических эффектов противовирусного препарата на основе фавипиравира у коморбидных пациентов с COVID-19 на амбулаторном этапе лечения [ACTIVE_FROM_X] => 2021-12-05 00:00:00 [~ACTIVE_FROM_X] => 2021-12-05 00:00:00 [ACTIVE_FROM] => 05.12.2021 [~ACTIVE_FROM] => 05.12.2021 [TIMESTAMP_X] => 25.01.2022 19:51:50 [~TIMESTAMP_X] => 25.01.2022 19:51:50 [DETAIL_PAGE_URL] => /research/izuchenie-kliniko-patogeneticheskikh-effektov-protivovirusnogo-preparata-na-osnove-favipiravira-u-ko/ [~DETAIL_PAGE_URL] => /research/izuchenie-kliniko-patogeneticheskikh-effektov-protivovirusnogo-preparata-na-osnove-favipiravira-u-ko/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Открытое проспективное сравнительное исследование эффективности применения препарата «Арепливир®» (фавипиравир) в дебюте COVID-19 у коморбидных пациентов [~PREVIEW_TEXT] => Открытое проспективное сравнительное исследование эффективности применения препарата «Арепливир®» (фавипиравир) в дебюте COVID-19 у коморбидных пациентов [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [PREVIEW_PICTURE] => Array ( [ID] => 1580 [TIMESTAMP_X] => 25.01.2022 19:51:50 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 221816 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/4ed/ed51fgk8idnqnf7cs2bkb9ekcvy4m3l9 [FILE_NAME] => r_pm_5.jpg [ORIGINAL_NAME] => r_pm_5.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => dc76696f03a7926d115fb980fa21995f [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/4ed/ed51fgk8idnqnf7cs2bkb9ekcvy4m3l9/r_pm_5.jpg [UNSAFE_SRC] => /upload/iblock/4ed/ed51fgk8idnqnf7cs2bkb9ekcvy4m3l9/r_pm_5.jpg [SAFE_SRC] => /upload/iblock/4ed/ed51fgk8idnqnf7cs2bkb9ekcvy4m3l9/r_pm_5.jpg [ALT] => Изучение клинико-патогенетических эффектов противовирусного препарата на основе фавипиравира у коморбидных пациентов с COVID-19 на амбулаторном этапе лечения [TITLE] => Изучение клинико-патогенетических эффектов противовирусного препарата на основе фавипиравира у коморбидных пациентов с COVID-19 на амбулаторном этапе лечения ) [~PREVIEW_PICTURE] => 1580 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => izuchenie-kliniko-patogeneticheskikh-effektov-protivovirusnogo-preparata-na-osnove-favipiravira-u-ko [~CODE] => izuchenie-kliniko-patogeneticheskikh-effektov-protivovirusnogo-preparata-na-osnove-favipiravira-u-ko [EXTERNAL_ID] => 1349 [~EXTERNAL_ID] => 1349 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 5 декабря 2021 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112279 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1581 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112280 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1581 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112279 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия COVID-19 ) ) [IPROPERTY_VALUES] => Array ( ) ) [1] => Array ( [ID] => 1351 [~ID] => 1351 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Экспертный совет: «Возможности этиотропной терапии респираторных инфекций, вызванных РНК-вирусами» [~NAME] => Экспертный совет: «Возможности этиотропной терапии респираторных инфекций, вызванных РНК-вирусами» [ACTIVE_FROM_X] => 2021-04-26 00:00:00 [~ACTIVE_FROM_X] => 2021-04-26 00:00:00 [ACTIVE_FROM] => 26.04.2021 [~ACTIVE_FROM] => 26.04.2021 [TIMESTAMP_X] => 26.01.2022 17:43:51 [~TIMESTAMP_X] => 26.01.2022 17:43:51 [DETAIL_PAGE_URL] => /research/ekspertnyy-sovet-vozmozhnosti-etiotropnoy-terapii-respiratornykh-infektsiy-vyzvannykh-rnk-virusami/ [~DETAIL_PAGE_URL] => /research/ekspertnyy-sovet-vozmozhnosti-etiotropnoy-terapii-respiratornykh-infektsiy-vyzvannykh-rnk-virusami/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => 26 апреля 2021 года в г. Москва под эгидой консорциума академического содружества по изучению коронавирусной инфекции состоялся экспертный совет и Российского научного медицинского общества терапевтов и, посвященный современным аспектам этиотропной терапии новой коронавирусной инфекции и других заболеваний, вызванных РНК-вирусами.



[~DETAIL_TEXT] => 26 апреля 2021 года в г. Москва под эгидой консорциума академического содружества по изучению коронавирусной инфекции состоялся экспертный совет и Российского научного медицинского общества терапевтов и, посвященный современным аспектам этиотропной терапии новой коронавирусной инфекции и других заболеваний, вызванных РНК-вирусами.



[DETAIL_TEXT_TYPE] => html [~DETAIL_TEXT_TYPE] => html [PREVIEW_TEXT] => Под эгидой консорциума академического содружества по изучению коронавирусной инфекции состоялся экспертный совет и Российского научного медицинского общества терапевтов и, посвященный современным аспектам этиотропной терапии новой коронавирусной инфекции и других заболеваний, вызванных РНК-вирусами. [~PREVIEW_TEXT] => Под эгидой консорциума академического содружества по изучению коронавирусной инфекции состоялся экспертный совет и Российского научного медицинского общества терапевтов и, посвященный современным аспектам этиотропной терапии новой коронавирусной инфекции и других заболеваний, вызванных РНК-вирусами. [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [PREVIEW_PICTURE] => Array ( [ID] => 1582 [TIMESTAMP_X] => 26.01.2022 17:43:51 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 304153 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/40c/1tkswd7eiuvdvvf6fxqlivk3ixyqgjdc [FILE_NAME] => r_pm_6.jpg [ORIGINAL_NAME] => r_pm_6.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 9cd311bcada3753f22be024fc3c09e36 [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/40c/1tkswd7eiuvdvvf6fxqlivk3ixyqgjdc/r_pm_6.jpg [UNSAFE_SRC] => /upload/iblock/40c/1tkswd7eiuvdvvf6fxqlivk3ixyqgjdc/r_pm_6.jpg [SAFE_SRC] => /upload/iblock/40c/1tkswd7eiuvdvvf6fxqlivk3ixyqgjdc/r_pm_6.jpg [ALT] => Экспертный совет: «Возможности этиотропной терапии респираторных инфекций, вызванных РНК-вирусами» [TITLE] => Экспертный совет: «Возможности этиотропной терапии респираторных инфекций, вызванных РНК-вирусами» ) [~PREVIEW_PICTURE] => 1582 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => ekspertnyy-sovet-vozmozhnosti-etiotropnoy-terapii-respiratornykh-infektsiy-vyzvannykh-rnk-virusami [~CODE] => ekspertnyy-sovet-vozmozhnosti-etiotropnoy-terapii-respiratornykh-infektsiy-vyzvannykh-rnk-virusami [EXTERNAL_ID] => 1350 [~EXTERNAL_ID] => 1350 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 26 апреля 2021 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 115316 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1583 [1] => 1584 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112282 [1] => 112283 ) [DESCRIPTION] => Array ( [0] => Резолюция совета экспертов [1] => Члены экспертного совета ) [~VALUE] => Array ( [0] => 1583 [1] => 1584 ) [~DESCRIPTION] => Array ( [0] => Резолюция совета экспертов [1] => Члены экспертного совета ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 115316 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия COVID-19 ) ) [IPROPERTY_VALUES] => Array ( ) ) [2] => Array ( [ID] => 1358 [~ID] => 1358 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Боткинские чтения [~NAME] => Боткинские чтения [ACTIVE_FROM_X] => 2021-04-24 00:00:00 [~ACTIVE_FROM_X] => 2021-04-24 00:00:00 [ACTIVE_FROM] => 24.04.2021 [~ACTIVE_FROM] => 24.04.2021 [TIMESTAMP_X] => 26.01.2022 11:30:36 [~TIMESTAMP_X] => 26.01.2022 11:30:36 [DETAIL_PAGE_URL] => /research/vserossiyskiy-terapevticheskiy-kongress-s-mezhdunarodnym-uchastiem-botkinskie-chteniya/ [~DETAIL_PAGE_URL] => /research/vserossiyskiy-terapevticheskiy-kongress-s-mezhdunarodnym-uchastiem-botkinskie-chteniya/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Сборник тезисов Всероссийского терапевтического конгресса с международным участием. [~PREVIEW_TEXT] => Сборник тезисов Всероссийского терапевтического конгресса с международным участием. [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [PREVIEW_PICTURE] => Array ( [ID] => 1597 [TIMESTAMP_X] => 26.01.2022 11:30:36 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 178347 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/0f4/xx85e4sj8swskivfglfxys1lq7uer4zc [FILE_NAME] => r_pm_13.jpg [ORIGINAL_NAME] => r_pm_13.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 62f627a2d112cb0031c63b75ec0566d9 [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/0f4/xx85e4sj8swskivfglfxys1lq7uer4zc/r_pm_13.jpg [UNSAFE_SRC] => /upload/iblock/0f4/xx85e4sj8swskivfglfxys1lq7uer4zc/r_pm_13.jpg [SAFE_SRC] => /upload/iblock/0f4/xx85e4sj8swskivfglfxys1lq7uer4zc/r_pm_13.jpg [ALT] => Боткинские чтения [TITLE] => Боткинские чтения ) [~PREVIEW_PICTURE] => 1597 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => vserossiyskiy-terapevticheskiy-kongress-s-mezhdunarodnym-uchastiem-botkinskie-chteniya [~CODE] => vserossiyskiy-terapevticheskiy-kongress-s-mezhdunarodnym-uchastiem-botkinskie-chteniya [EXTERNAL_ID] => 1357 [~EXTERNAL_ID] => 1357 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 24 апреля 2021 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Материалы конференций ) [VALUE_XML_ID] => Array ( [0] => materials ) [VALUE_SORT] => Array ( [0] => 500 ) [VALUE] => Array ( [0] => Материалы конференций ) [PROPERTY_VALUE_ID] => Array ( [0] => 114712 ) [VALUE_ENUM_ID] => Array ( [0] => 166 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Материалы конференций ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1598 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112297 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1598 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Материалы конференций ) [VALUE_XML_ID] => Array ( [0] => materials ) [VALUE_SORT] => Array ( [0] => 500 ) [VALUE] => Array ( [0] => Материалы конференций ) [PROPERTY_VALUE_ID] => Array ( [0] => 114712 ) [VALUE_ENUM_ID] => Array ( [0] => 166 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Материалы конференций ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Материалы конференций ) ) [IPROPERTY_VALUES] => Array ( ) ) [3] => Array ( [ID] => 1360 [~ID] => 1360 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Лечение остеоартроза крупных и мелких суставов с использованием инъекционного хондропротектора комплексного действия [~NAME] => Лечение остеоартроза крупных и мелких суставов с использованием инъекционного хондропротектора комплексного действия [ACTIVE_FROM_X] => 2021-04-01 00:00:00 [~ACTIVE_FROM_X] => 2021-04-01 00:00:00 [ACTIVE_FROM] => 01.04.2021 [~ACTIVE_FROM] => 01.04.2021 [TIMESTAMP_X] => 26.01.2022 11:54:03 [~TIMESTAMP_X] => 26.01.2022 11:54:03 [DETAIL_PAGE_URL] => /research/lechenie-osteoartroza-krupnykh-i-melkikh-sustavov-s-ispolzovaniem-inektsionnogo-khondroprotektora-ko/ [~DETAIL_PAGE_URL] => /research/lechenie-osteoartroza-krupnykh-i-melkikh-sustavov-s-ispolzovaniem-inektsionnogo-khondroprotektora-ko/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => В многоцентровом исследовании оценивали эффективность и переносимость инъекционного средства замедленного действия для терапии остеоартроза крупных и мелких суставов. [~PREVIEW_TEXT] => В многоцентровом исследовании оценивали эффективность и переносимость инъекционного средства замедленного действия для терапии остеоартроза крупных и мелких суставов. [PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 1601 [TIMESTAMP_X] => 26.01.2022 11:54:03 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 232896 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/907/wvnafidkrwrjm5qiya9z93903qlsqmhu [FILE_NAME] => r_pm_15.jpg [ORIGINAL_NAME] => r_pm_15.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => b4ad26b0985eb82b08e918390558a4d7 [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/907/wvnafidkrwrjm5qiya9z93903qlsqmhu/r_pm_15.jpg [UNSAFE_SRC] => /upload/iblock/907/wvnafidkrwrjm5qiya9z93903qlsqmhu/r_pm_15.jpg [SAFE_SRC] => /upload/iblock/907/wvnafidkrwrjm5qiya9z93903qlsqmhu/r_pm_15.jpg [ALT] => Лечение остеоартроза крупных и мелких суставов с использованием инъекционного хондропротектора комплексного действия [TITLE] => Лечение остеоартроза крупных и мелких суставов с использованием инъекционного хондропротектора комплексного действия ) [~PREVIEW_PICTURE] => 1601 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => lechenie-osteoartroza-krupnykh-i-melkikh-sustavov-s-ispolzovaniem-inektsionnogo-khondroprotektora-ko [~CODE] => lechenie-osteoartroza-krupnykh-i-melkikh-sustavov-s-ispolzovaniem-inektsionnogo-khondroprotektora-ko [EXTERNAL_ID] => 1359 [~EXTERNAL_ID] => 1359 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 1 апреля 2021 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия остеоартроза ) [VALUE_XML_ID] => Array ( [0] => osteoarthritis ) [VALUE_SORT] => Array ( [0] => 500 ) [VALUE] => Array ( [0] => Терапия остеоартроза ) [PROPERTY_VALUE_ID] => Array ( [0] => 114713 ) [VALUE_ENUM_ID] => Array ( [0] => 167 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия остеоартроза ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1602 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112301 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1602 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия остеоартроза ) [VALUE_XML_ID] => Array ( [0] => osteoarthritis ) [VALUE_SORT] => Array ( [0] => 500 ) [VALUE] => Array ( [0] => Терапия остеоартроза ) [PROPERTY_VALUE_ID] => Array ( [0] => 114713 ) [VALUE_ENUM_ID] => Array ( [0] => 167 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия остеоартроза ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия остеоартроза ) ) [IPROPERTY_VALUES] => Array ( ) ) [4] => Array ( [ID] => 1357 [~ID] => 1357 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Медицинская реабилитация женщин с ожирением после родов [~NAME] => Медицинская реабилитация женщин с ожирением после родов [ACTIVE_FROM_X] => 2021-01-13 00:00:00 [~ACTIVE_FROM_X] => 2021-01-13 00:00:00 [ACTIVE_FROM] => 13.01.2021 [~ACTIVE_FROM] => 13.01.2021 [TIMESTAMP_X] => 25.01.2022 19:51:51 [~TIMESTAMP_X] => 25.01.2022 19:51:51 [DETAIL_PAGE_URL] => /research/meditsinskaya-reabilitatsiya-zhenshchin-s-ozhireniem-posle-rodov/ [~DETAIL_PAGE_URL] => /research/meditsinskaya-reabilitatsiya-zhenshchin-s-ozhireniem-posle-rodov/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Определение эффективности комплексной программы послеродовой реабилитации, проводимой в течение 12 месяцев у женщин с ожирением. [~PREVIEW_TEXT] => Определение эффективности комплексной программы послеродовой реабилитации, проводимой в течение 12 месяцев у женщин с ожирением. [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [PREVIEW_PICTURE] => Array ( [ID] => 1595 [TIMESTAMP_X] => 25.01.2022 19:51:51 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 356491 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/8c8/nt1k3cc9ee4xoit7gueh5ql2qooghkmm [FILE_NAME] => r_pm_12.jpg [ORIGINAL_NAME] => r_pm_12.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 693379d86e4bc86421041ad4ecd0f4bf [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/8c8/nt1k3cc9ee4xoit7gueh5ql2qooghkmm/r_pm_12.jpg [UNSAFE_SRC] => /upload/iblock/8c8/nt1k3cc9ee4xoit7gueh5ql2qooghkmm/r_pm_12.jpg [SAFE_SRC] => /upload/iblock/8c8/nt1k3cc9ee4xoit7gueh5ql2qooghkmm/r_pm_12.jpg [ALT] => Медицинская реабилитация женщин с ожирением после родов [TITLE] => Медицинская реабилитация женщин с ожирением после родов ) [~PREVIEW_PICTURE] => 1595 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => meditsinskaya-reabilitatsiya-zhenshchin-s-ozhireniem-posle-rodov [~CODE] => meditsinskaya-reabilitatsiya-zhenshchin-s-ozhireniem-posle-rodov [EXTERNAL_ID] => 1356 [~EXTERNAL_ID] => 1356 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 13 января 2021 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия ожирения ) [VALUE_XML_ID] => Array ( [0] => obesity ) [VALUE_SORT] => Array ( [0] => 200 ) [VALUE] => Array ( [0] => Терапия ожирения ) [PROPERTY_VALUE_ID] => Array ( [0] => 112294 ) [VALUE_ENUM_ID] => Array ( [0] => 165 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия ожирения ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1596 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112295 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1596 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия ожирения ) [VALUE_XML_ID] => Array ( [0] => obesity ) [VALUE_SORT] => Array ( [0] => 200 ) [VALUE] => Array ( [0] => Терапия ожирения ) [PROPERTY_VALUE_ID] => Array ( [0] => 112294 ) [VALUE_ENUM_ID] => Array ( [0] => 165 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия ожирения ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия ожирения ) ) [IPROPERTY_VALUES] => Array ( ) ) [5] => Array ( [ID] => 1349 [~ID] => 1349 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Особенности коронавирусной инфекции COVID-19 и возможности раннего начала этиотропной терапии. Результаты клинического применения [~NAME] => Особенности коронавирусной инфекции COVID-19 и возможности раннего начала этиотропной терапии. Результаты клинического применения [ACTIVE_FROM_X] => 2020-09-28 00:00:00 [~ACTIVE_FROM_X] => 2020-09-28 00:00:00 [ACTIVE_FROM] => 28.09.2020 [~ACTIVE_FROM] => 28.09.2020 [TIMESTAMP_X] => 25.01.2022 19:51:50 [~TIMESTAMP_X] => 25.01.2022 19:51:50 [DETAIL_PAGE_URL] => /research/osobennosti-koronavirusnoy-infektsii-covid-19-i-vozmozhnosti-rannego-nachala-etiotropnoy-terapii-rez/ [~DETAIL_PAGE_URL] => /research/osobennosti-koronavirusnoy-infektsii-covid-19-i-vozmozhnosti-rannego-nachala-etiotropnoy-terapii-rez/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => В статье представлены результаты клинического исследования эффективности и безопасности этиотропной терапии у пациентов, госпитализированных с новой коронавирусной инфекцией, вызванной вирусом SARS-CoV-2 [~PREVIEW_TEXT] => В статье представлены результаты клинического исследования эффективности и безопасности этиотропной терапии у пациентов, госпитализированных с новой коронавирусной инфекцией, вызванной вирусом SARS-CoV-2 [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [PREVIEW_PICTURE] => Array ( [ID] => 1578 [TIMESTAMP_X] => 25.01.2022 19:51:50 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 226036 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/298/fabkg11fmtjvaeclvycwhjf4zghe6gpi [FILE_NAME] => r_pm_4.jpg [ORIGINAL_NAME] => r_pm_4.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 055d5cd011d87e0d98c4a86ebc8703de [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/298/fabkg11fmtjvaeclvycwhjf4zghe6gpi/r_pm_4.jpg [UNSAFE_SRC] => /upload/iblock/298/fabkg11fmtjvaeclvycwhjf4zghe6gpi/r_pm_4.jpg [SAFE_SRC] => /upload/iblock/298/fabkg11fmtjvaeclvycwhjf4zghe6gpi/r_pm_4.jpg [ALT] => Особенности коронавирусной инфекции COVID-19 и возможности раннего начала этиотропной терапии. Результаты клинического применения [TITLE] => Особенности коронавирусной инфекции COVID-19 и возможности раннего начала этиотропной терапии. Результаты клинического применения ) [~PREVIEW_PICTURE] => 1578 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => osobennosti-koronavirusnoy-infektsii-covid-19-i-vozmozhnosti-rannego-nachala-etiotropnoy-terapii-rez [~CODE] => osobennosti-koronavirusnoy-infektsii-covid-19-i-vozmozhnosti-rannego-nachala-etiotropnoy-terapii-rez [EXTERNAL_ID] => 1348 [~EXTERNAL_ID] => 1348 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 28 сентября 2020 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112277 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1579 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112278 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1579 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112277 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия COVID-19 ) ) [IPROPERTY_VALUES] => Array ( ) ) [6] => Array ( [ID] => 1346 [~ID] => 1346 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Новые возможности направленной противовирусной терапии COVID-19: результаты многоцентрового клинического исследования эффективности и безопасности применения препарата Арепливир [~NAME] => Новые возможности направленной противовирусной терапии COVID-19: результаты многоцентрового клинического исследования эффективности и безопасности применения препарата Арепливир [ACTIVE_FROM_X] => 2020-09-02 00:00:00 [~ACTIVE_FROM_X] => 2020-09-02 00:00:00 [ACTIVE_FROM] => 02.09.2020 [~ACTIVE_FROM] => 02.09.2020 [TIMESTAMP_X] => 25.01.2022 19:51:50 [~TIMESTAMP_X] => 25.01.2022 19:51:50 [DETAIL_PAGE_URL] => /research/novye-vozmozhnosti-napravlennoy-protivovirusnoy-terapii-covid-19-rezultaty-mnogotsentrovogo-kliniche/ [~DETAIL_PAGE_URL] => /research/novye-vozmozhnosti-napravlennoy-protivovirusnoy-terapii-covid-19-rezultaty-mnogotsentrovogo-kliniche/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Цель исследования – изучить эффективность и безопасность применения препарата фавипиравир (Арепливир) у больных COVID-19 по сравнению с рекомендованной стандартной терапией. [~PREVIEW_TEXT] => Цель исследования – изучить эффективность и безопасность применения препарата фавипиравир (Арепливир) у больных COVID-19 по сравнению с рекомендованной стандартной терапией. [PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 1572 [TIMESTAMP_X] => 25.01.2022 19:51:50 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 222763 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/b4f/y5apurw6j7rdwsz9g2e2whuox5cz26nr [FILE_NAME] => r_pm_1.jpg [ORIGINAL_NAME] => r_pm_1.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => b94dbc311608055eb47c4b10bb42a0de [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/b4f/y5apurw6j7rdwsz9g2e2whuox5cz26nr/r_pm_1.jpg [UNSAFE_SRC] => /upload/iblock/b4f/y5apurw6j7rdwsz9g2e2whuox5cz26nr/r_pm_1.jpg [SAFE_SRC] => /upload/iblock/b4f/y5apurw6j7rdwsz9g2e2whuox5cz26nr/r_pm_1.jpg [ALT] => Новые возможности направленной противовирусной терапии COVID-19: результаты многоцентрового клинического исследования эффективности и безопасности применения препарата Арепливир [TITLE] => Новые возможности направленной противовирусной терапии COVID-19: результаты многоцентрового клинического исследования эффективности и безопасности применения препарата Арепливир ) [~PREVIEW_PICTURE] => 1572 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => novye-vozmozhnosti-napravlennoy-protivovirusnoy-terapii-covid-19-rezultaty-mnogotsentrovogo-kliniche [~CODE] => novye-vozmozhnosti-napravlennoy-protivovirusnoy-terapii-covid-19-rezultaty-mnogotsentrovogo-kliniche [EXTERNAL_ID] => 1344 [~EXTERNAL_ID] => 1344 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 2 сентября 2020 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112271 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1573 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112272 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1573 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112271 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия COVID-19 ) ) [IPROPERTY_VALUES] => Array ( ) ) [7] => Array ( [ID] => 1347 [~ID] => 1347 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Эффективность этиотропной терапии новой коронавирусной инфекции препаратом Арепливир (фавипиравир) в зависимости от времени начала лечения (клиническое наблюдение) [~NAME] => Эффективность этиотропной терапии новой коронавирусной инфекции препаратом Арепливир (фавипиравир) в зависимости от времени начала лечения (клиническое наблюдение) [ACTIVE_FROM_X] => 2020-09-02 00:00:00 [~ACTIVE_FROM_X] => 2020-09-02 00:00:00 [ACTIVE_FROM] => 02.09.2020 [~ACTIVE_FROM] => 02.09.2020 [TIMESTAMP_X] => 25.01.2022 19:51:50 [~TIMESTAMP_X] => 25.01.2022 19:51:50 [DETAIL_PAGE_URL] => /research/effektivnost-etiotropnoy-terapii-novoy-koronavirusnoy-infektsii-preparatom-areplivir-favipiravir-v-z/ [~DETAIL_PAGE_URL] => /research/effektivnost-etiotropnoy-terapii-novoy-koronavirusnoy-infektsii-preparatom-areplivir-favipiravir-v-z/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => В статье описаны клинические наблюдения, демонстрирующие улучшение клинического статуса пациентов, на фоне применения препарата Арепливир (фавипиравир), блокирующего репликацию вируса и доказавшего свою эффективность, в том числе в контролируемых исследованиях. [~PREVIEW_TEXT] => В статье описаны клинические наблюдения, демонстрирующие улучшение клинического статуса пациентов, на фоне применения препарата Арепливир (фавипиравир), блокирующего репликацию вируса и доказавшего свою эффективность, в том числе в контролируемых исследованиях. [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [PREVIEW_PICTURE] => Array ( [ID] => 1574 [TIMESTAMP_X] => 25.01.2022 19:51:50 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 351330 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/a2c/2gpwgd9i5ipb0ltd3ofyal0l2swkqy4v [FILE_NAME] => r_pm_2.jpg [ORIGINAL_NAME] => r_pm_2.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 56c3ffbea9b86022ba8d9f905e12f044 [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/a2c/2gpwgd9i5ipb0ltd3ofyal0l2swkqy4v/r_pm_2.jpg [UNSAFE_SRC] => /upload/iblock/a2c/2gpwgd9i5ipb0ltd3ofyal0l2swkqy4v/r_pm_2.jpg [SAFE_SRC] => /upload/iblock/a2c/2gpwgd9i5ipb0ltd3ofyal0l2swkqy4v/r_pm_2.jpg [ALT] => Эффективность этиотропной терапии новой коронавирусной инфекции препаратом Арепливир (фавипиравир) в зависимости от времени начала лечения (клиническое наблюдение) [TITLE] => Эффективность этиотропной терапии новой коронавирусной инфекции препаратом Арепливир (фавипиравир) в зависимости от времени начала лечения (клиническое наблюдение) ) [~PREVIEW_PICTURE] => 1574 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => effektivnost-etiotropnoy-terapii-novoy-koronavirusnoy-infektsii-preparatom-areplivir-favipiravir-v-z [~CODE] => effektivnost-etiotropnoy-terapii-novoy-koronavirusnoy-infektsii-preparatom-areplivir-favipiravir-v-z [EXTERNAL_ID] => 1345 [~EXTERNAL_ID] => 1345 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 2 сентября 2020 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112273 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1575 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112274 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1575 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112273 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия COVID-19 ) ) [IPROPERTY_VALUES] => Array ( ) ) [8] => Array ( [ID] => 1348 [~ID] => 1348 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => COVID-19: набор симптомов или системная патология? Клиническая лекция [~NAME] => COVID-19: набор симптомов или системная патология? Клиническая лекция [ACTIVE_FROM_X] => 2020-09-02 00:00:00 [~ACTIVE_FROM_X] => 2020-09-02 00:00:00 [ACTIVE_FROM] => 02.09.2020 [~ACTIVE_FROM] => 02.09.2020 [TIMESTAMP_X] => 26.01.2022 11:58:08 [~TIMESTAMP_X] => 26.01.2022 11:58:08 [DETAIL_PAGE_URL] => /research/covid-19-nabor-simptomov-ili-sistemnaya-patologiya-klinicheskaya-lektsiya/ [~DETAIL_PAGE_URL] => /research/covid-19-nabor-simptomov-ili-sistemnaya-patologiya-klinicheskaya-lektsiya/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Часть 2. Арепливир (фавипиравир) в терапии пациентов с коронавирусной инфекцией: предпосылки для назначения и первые результаты использования. В статье представлена информация о безопасности и клинической эффективности фавипиравира в лечении инфекционных заболеваний, вызванных РНК-вирусами, в частности COVID-19, а также возможности применения препарата Арепливир (фавипиравир) у пациентов с новой коронавирусной инфекцией. [~PREVIEW_TEXT] => Часть 2. Арепливир (фавипиравир) в терапии пациентов с коронавирусной инфекцией: предпосылки для назначения и первые результаты использования. В статье представлена информация о безопасности и клинической эффективности фавипиравира в лечении инфекционных заболеваний, вызванных РНК-вирусами, в частности COVID-19, а также возможности применения препарата Арепливир (фавипиравир) у пациентов с новой коронавирусной инфекцией. [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [PREVIEW_PICTURE] => Array ( [ID] => 1576 [TIMESTAMP_X] => 26.01.2022 11:58:08 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 294810 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/087/luy5wkmj0u0iuz4irb41refq73zyo112 [FILE_NAME] => r_pm_3.jpg [ORIGINAL_NAME] => r_pm_3.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 066e0b534e754f9972142a07f8dff16d [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/087/luy5wkmj0u0iuz4irb41refq73zyo112/r_pm_3.jpg [UNSAFE_SRC] => /upload/iblock/087/luy5wkmj0u0iuz4irb41refq73zyo112/r_pm_3.jpg [SAFE_SRC] => /upload/iblock/087/luy5wkmj0u0iuz4irb41refq73zyo112/r_pm_3.jpg [ALT] => COVID-19: набор симптомов или системная патология? Клиническая лекция [TITLE] => COVID-19: набор симптомов или системная патология? Клиническая лекция ) [~PREVIEW_PICTURE] => 1576 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => covid-19-nabor-simptomov-ili-sistemnaya-patologiya-klinicheskaya-lektsiya [~CODE] => covid-19-nabor-simptomov-ili-sistemnaya-patologiya-klinicheskaya-lektsiya [EXTERNAL_ID] => 1347 [~EXTERNAL_ID] => 1347 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 2 сентября 2020 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 114714 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1577 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112276 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1577 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 114714 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия COVID-19 ) ) [IPROPERTY_VALUES] => Array ( ) ) [9] => Array ( [ID] => 1352 [~ID] => 1352 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Краткий отчет о результатах клинического исследования лекарственного препарата Арепливир [~NAME] => Краткий отчет о результатах клинического исследования лекарственного препарата Арепливир [ACTIVE_FROM_X] => 2020-08-17 00:00:00 [~ACTIVE_FROM_X] => 2020-08-17 00:00:00 [ACTIVE_FROM] => 17.08.2020 [~ACTIVE_FROM] => 17.08.2020 [TIMESTAMP_X] => 25.01.2022 19:51:50 [~TIMESTAMP_X] => 25.01.2022 19:51:50 [DETAIL_PAGE_URL] => /research/kratkiy-otchet-o-rezultatakh-klinicheskogo-issledovaniya-lekarstvennogo-preparata-areplivir/ [~DETAIL_PAGE_URL] => /research/kratkiy-otchet-o-rezultatakh-klinicheskogo-issledovaniya-lekarstvennogo-preparata-areplivir/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Открытое рандомизированное многоцентровое сравнительное исследование эффективности и безопасности препарата АРЕПЛИВИР, таблетки, покрытые пленочной оболочкой (ООО «ПРОМОМЕД РУС», Россия) у пациентов, госпитализированных с COVID-19. [~PREVIEW_TEXT] => Открытое рандомизированное многоцентровое сравнительное исследование эффективности и безопасности препарата АРЕПЛИВИР, таблетки, покрытые пленочной оболочкой (ООО «ПРОМОМЕД РУС», Россия) у пациентов, госпитализированных с COVID-19. [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [PREVIEW_PICTURE] => Array ( [ID] => 1585 [TIMESTAMP_X] => 25.01.2022 19:51:50 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 294110 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/49b/aerui78zm6ajo8bo8aqmttnp04o2u60r [FILE_NAME] => r_pm_7.jpg [ORIGINAL_NAME] => r_pm_7.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 7da378afa183e400367707fa0fc65565 [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/49b/aerui78zm6ajo8bo8aqmttnp04o2u60r/r_pm_7.jpg [UNSAFE_SRC] => /upload/iblock/49b/aerui78zm6ajo8bo8aqmttnp04o2u60r/r_pm_7.jpg [SAFE_SRC] => /upload/iblock/49b/aerui78zm6ajo8bo8aqmttnp04o2u60r/r_pm_7.jpg [ALT] => Краткий отчет о результатах клинического исследования лекарственного препарата Арепливир [TITLE] => Краткий отчет о результатах клинического исследования лекарственного препарата Арепливир ) [~PREVIEW_PICTURE] => 1585 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => kratkiy-otchet-o-rezultatakh-klinicheskogo-issledovaniya-lekarstvennogo-preparata-areplivir [~CODE] => kratkiy-otchet-o-rezultatakh-klinicheskogo-issledovaniya-lekarstvennogo-preparata-areplivir [EXTERNAL_ID] => 1351 [~EXTERNAL_ID] => 1351 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 17 августа 2020 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112284 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1586 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112285 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1586 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия COVID-19 ) [VALUE_XML_ID] => Array ( [0] => covid ) [VALUE_SORT] => Array ( [0] => 100 ) [VALUE] => Array ( [0] => Терапия COVID-19 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112284 ) [VALUE_ENUM_ID] => Array ( [0] => 164 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия COVID-19 ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия COVID-19 ) ) [IPROPERTY_VALUES] => Array ( ) ) [10] => Array ( [ID] => 1355 [~ID] => 1355 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Преимущества долгосрочного управления метаболическим здоровьем у пациентов с ожирением и ранними нарушениями углеводного обмена [~NAME] => Преимущества долгосрочного управления метаболическим здоровьем у пациентов с ожирением и ранними нарушениями углеводного обмена [ACTIVE_FROM_X] => 2020-06-18 00:00:00 [~ACTIVE_FROM_X] => 2020-06-18 00:00:00 [ACTIVE_FROM] => 18.06.2020 [~ACTIVE_FROM] => 18.06.2020 [TIMESTAMP_X] => 25.01.2022 19:51:51 [~TIMESTAMP_X] => 25.01.2022 19:51:51 [DETAIL_PAGE_URL] => /research/preimushchestva-dolgosrochnogo-upravleniya-metabolicheskim-zdorovem-u-patsientov-s-ozhireniem-i-rann/ [~DETAIL_PAGE_URL] => /research/preimushchestva-dolgosrochnogo-upravleniya-metabolicheskim-zdorovem-u-patsientov-s-ozhireniem-i-rann/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => В статье представлены результаты наблюдательного исследования, демонстрирующие преимущества терапии фиксированной комбинацией сибутрамина и метформина в течение 12 мес в достижении метаболического здоровья. [~PREVIEW_TEXT] => В статье представлены результаты наблюдательного исследования, демонстрирующие преимущества терапии фиксированной комбинацией сибутрамина и метформина в течение 12 мес в достижении метаболического здоровья. [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [PREVIEW_PICTURE] => Array ( [ID] => 1591 [TIMESTAMP_X] => 25.01.2022 19:51:50 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 225797 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/3d5/n71zr22fhkedg1k9nit5nz0c0d4l5m3c [FILE_NAME] => r_pm_10.jpg [ORIGINAL_NAME] => r_pm_10.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => fad4496663af927f711d87359d48709f [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/3d5/n71zr22fhkedg1k9nit5nz0c0d4l5m3c/r_pm_10.jpg [UNSAFE_SRC] => /upload/iblock/3d5/n71zr22fhkedg1k9nit5nz0c0d4l5m3c/r_pm_10.jpg [SAFE_SRC] => /upload/iblock/3d5/n71zr22fhkedg1k9nit5nz0c0d4l5m3c/r_pm_10.jpg [ALT] => Преимущества долгосрочного управления метаболическим здоровьем у пациентов с ожирением и ранними нарушениями углеводного обмена [TITLE] => Преимущества долгосрочного управления метаболическим здоровьем у пациентов с ожирением и ранними нарушениями углеводного обмена ) [~PREVIEW_PICTURE] => 1591 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => preimushchestva-dolgosrochnogo-upravleniya-metabolicheskim-zdorovem-u-patsientov-s-ozhireniem-i-rann [~CODE] => preimushchestva-dolgosrochnogo-upravleniya-metabolicheskim-zdorovem-u-patsientov-s-ozhireniem-i-rann [EXTERNAL_ID] => 1354 [~EXTERNAL_ID] => 1354 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 18 июня 2020 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия ожирения ) [VALUE_XML_ID] => Array ( [0] => obesity ) [VALUE_SORT] => Array ( [0] => 200 ) [VALUE] => Array ( [0] => Терапия ожирения ) [PROPERTY_VALUE_ID] => Array ( [0] => 112290 ) [VALUE_ENUM_ID] => Array ( [0] => 165 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия ожирения ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1592 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112291 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1592 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия ожирения ) [VALUE_XML_ID] => Array ( [0] => obesity ) [VALUE_SORT] => Array ( [0] => 200 ) [VALUE] => Array ( [0] => Терапия ожирения ) [PROPERTY_VALUE_ID] => Array ( [0] => 112290 ) [VALUE_ENUM_ID] => Array ( [0] => 165 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия ожирения ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия ожирения ) ) [IPROPERTY_VALUES] => Array ( ) ) [11] => Array ( [ID] => 1362 [~ID] => 1362 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Роль дозированных, лечебных, физических нагрузок и медикаментозной терапии в лечении больных остеоартритом [~NAME] => Роль дозированных, лечебных, физических нагрузок и медикаментозной терапии в лечении больных остеоартритом [ACTIVE_FROM_X] => 2020-05-01 00:00:00 [~ACTIVE_FROM_X] => 2020-05-01 00:00:00 [ACTIVE_FROM] => 01.05.2020 [~ACTIVE_FROM] => 01.05.2020 [TIMESTAMP_X] => 26.01.2022 12:01:26 [~TIMESTAMP_X] => 26.01.2022 12:01:26 [DETAIL_PAGE_URL] => /research/rol-dozirovannykh-lechebnykh-fizicheskikh-nagruzok-i-medikamentoznoy-terapii-v-lechenii-bolnykh-oste/ [~DETAIL_PAGE_URL] => /research/rol-dozirovannykh-lechebnykh-fizicheskikh-nagruzok-i-medikamentoznoy-terapii-v-lechenii-bolnykh-oste/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Цель исследования — проанализировать безопасность и эффективность лечения остеоартрита суставов кистей комбинацией дозированных, физических, лечебных нагрузок с парентеральным введением отечественного аналога алфлутопа — АМБЕНЕ® Био (Ambene® Bio). [~PREVIEW_TEXT] => Цель исследования — проанализировать безопасность и эффективность лечения остеоартрита суставов кистей комбинацией дозированных, физических, лечебных нагрузок с парентеральным введением отечественного аналога алфлутопа — АМБЕНЕ® Био (Ambene® Bio). [PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 1605 [TIMESTAMP_X] => 26.01.2022 12:01:26 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 334627 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/119/aoe9of4bphq92i96kelg6ehrrhb88drd [FILE_NAME] => r_pm_17.jpg [ORIGINAL_NAME] => r_pm_17.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 1893802877c250527883cbd08907351a [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/119/aoe9of4bphq92i96kelg6ehrrhb88drd/r_pm_17.jpg [UNSAFE_SRC] => /upload/iblock/119/aoe9of4bphq92i96kelg6ehrrhb88drd/r_pm_17.jpg [SAFE_SRC] => /upload/iblock/119/aoe9of4bphq92i96kelg6ehrrhb88drd/r_pm_17.jpg [ALT] => Роль дозированных, лечебных, физических нагрузок и медикаментозной терапии в лечении больных остеоартритом [TITLE] => Роль дозированных, лечебных, физических нагрузок и медикаментозной терапии в лечении больных остеоартритом ) [~PREVIEW_PICTURE] => 1605 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => rol-dozirovannykh-lechebnykh-fizicheskikh-nagruzok-i-medikamentoznoy-terapii-v-lechenii-bolnykh-oste [~CODE] => rol-dozirovannykh-lechebnykh-fizicheskikh-nagruzok-i-medikamentoznoy-terapii-v-lechenii-bolnykh-oste [EXTERNAL_ID] => 1361 [~EXTERNAL_ID] => 1361 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 1 мая 2020 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия остеоартроза ) [VALUE_XML_ID] => Array ( [0] => osteoarthritis ) [VALUE_SORT] => Array ( [0] => 500 ) [VALUE] => Array ( [0] => Терапия остеоартроза ) [PROPERTY_VALUE_ID] => Array ( [0] => 114715 ) [VALUE_ENUM_ID] => Array ( [0] => 167 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия остеоартроза ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1606 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112305 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1606 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия остеоартроза ) [VALUE_XML_ID] => Array ( [0] => osteoarthritis ) [VALUE_SORT] => Array ( [0] => 500 ) [VALUE] => Array ( [0] => Терапия остеоартроза ) [PROPERTY_VALUE_ID] => Array ( [0] => 114715 ) [VALUE_ENUM_ID] => Array ( [0] => 167 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия остеоартроза ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия остеоартроза ) ) [IPROPERTY_VALUES] => Array ( ) ) [12] => Array ( [ID] => 1354 [~ID] => 1354 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Взаимосвязь ожирения и артериальной гипертензии: как влияние на аппетит может снизить артериальное давление? [~NAME] => Взаимосвязь ожирения и артериальной гипертензии: как влияние на аппетит может снизить артериальное давление? [ACTIVE_FROM_X] => 2020-03-12 00:00:00 [~ACTIVE_FROM_X] => 2020-03-12 00:00:00 [ACTIVE_FROM] => 12.03.2020 [~ACTIVE_FROM] => 12.03.2020 [TIMESTAMP_X] => 25.01.2022 19:51:50 [~TIMESTAMP_X] => 25.01.2022 19:51:50 [DETAIL_PAGE_URL] => /research/vzaimosvyaz-ozhireniya-i-arterialnoy-gipertenzii-kak-vliyanie-na-appetit-mozhet-snizit-arterialnoe-d/ [~DETAIL_PAGE_URL] => /research/vzaimosvyaz-ozhireniya-i-arterialnoy-gipertenzii-kak-vliyanie-na-appetit-mozhet-snizit-arterialnoe-d/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => В данной статье разобрана патогенетическая связь повышения артериального давления с ожирением, а также рассмотрено, как снижение массы тела влияет на изменение артериального давления, особенно в рамках медикаментозной коррекции избытка жировой ткани. [~PREVIEW_TEXT] => В данной статье разобрана патогенетическая связь повышения артериального давления с ожирением, а также рассмотрено, как снижение массы тела влияет на изменение артериального давления, особенно в рамках медикаментозной коррекции избытка жировой ткани. [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [PREVIEW_PICTURE] => Array ( [ID] => 1589 [TIMESTAMP_X] => 25.01.2022 19:51:50 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 256540 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/46d/iix824w2wcp68afz5firvodaf04hw57c [FILE_NAME] => r_pm_9.jpg [ORIGINAL_NAME] => r_pm_9.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 0bc36048d533cb7f38909d9d909d4dfe [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/46d/iix824w2wcp68afz5firvodaf04hw57c/r_pm_9.jpg [UNSAFE_SRC] => /upload/iblock/46d/iix824w2wcp68afz5firvodaf04hw57c/r_pm_9.jpg [SAFE_SRC] => /upload/iblock/46d/iix824w2wcp68afz5firvodaf04hw57c/r_pm_9.jpg [ALT] => Взаимосвязь ожирения и артериальной гипертензии: как влияние на аппетит может снизить артериальное давление? [TITLE] => Взаимосвязь ожирения и артериальной гипертензии: как влияние на аппетит может снизить артериальное давление? ) [~PREVIEW_PICTURE] => 1589 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => vzaimosvyaz-ozhireniya-i-arterialnoy-gipertenzii-kak-vliyanie-na-appetit-mozhet-snizit-arterialnoe-d [~CODE] => vzaimosvyaz-ozhireniya-i-arterialnoy-gipertenzii-kak-vliyanie-na-appetit-mozhet-snizit-arterialnoe-d [EXTERNAL_ID] => 1353 [~EXTERNAL_ID] => 1353 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 12 марта 2020 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия ожирения ) [VALUE_XML_ID] => Array ( [0] => obesity ) [VALUE_SORT] => Array ( [0] => 200 ) [VALUE] => Array ( [0] => Терапия ожирения ) [PROPERTY_VALUE_ID] => Array ( [0] => 112288 ) [VALUE_ENUM_ID] => Array ( [0] => 165 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия ожирения ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1590 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112289 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1590 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия ожирения ) [VALUE_XML_ID] => Array ( [0] => obesity ) [VALUE_SORT] => Array ( [0] => 200 ) [VALUE] => Array ( [0] => Терапия ожирения ) [PROPERTY_VALUE_ID] => Array ( [0] => 112288 ) [VALUE_ENUM_ID] => Array ( [0] => 165 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия ожирения ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия ожирения ) ) [IPROPERTY_VALUES] => Array ( ) ) [13] => Array ( [ID] => 1353 [~ID] => 1353 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Современные возможности управления метаболическим здоровьем у пациентов с ожирением и нарушениями углеводного обмена [~NAME] => Современные возможности управления метаболическим здоровьем у пациентов с ожирением и нарушениями углеводного обмена [ACTIVE_FROM_X] => 2020-03-12 00:00:00 [~ACTIVE_FROM_X] => 2020-03-12 00:00:00 [ACTIVE_FROM] => 12.03.2020 [~ACTIVE_FROM] => 12.03.2020 [TIMESTAMP_X] => 26.01.2022 12:06:31 [~TIMESTAMP_X] => 26.01.2022 12:06:31 [DETAIL_PAGE_URL] => /research/sovremennye-vozmozhnosti-upravleniya-metabolicheskim-zdorovem-u-patsientov-s-ozhireniem-i-narusheniya/ [~DETAIL_PAGE_URL] => /research/sovremennye-vozmozhnosti-upravleniya-metabolicheskim-zdorovem-u-patsientov-s-ozhireniem-i-narusheniya/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Исследование по использованию комбинированных препаратов, позволяющих воздействовать на разные патогенетические триггеры развития полиморбидной патологии при ожирении. [~PREVIEW_TEXT] => Исследование по использованию комбинированных препаратов, позволяющих воздействовать на разные патогенетические триггеры развития полиморбидной патологии при ожирении. [PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 1587 [TIMESTAMP_X] => 26.01.2022 12:06:31 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 227652 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/1e2/0nnhqo1xh8knvrj7ls0ul2nnz2f7kas0 [FILE_NAME] => r_pm_8.jpg [ORIGINAL_NAME] => r_pm_8.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 31aa3317047df52013a64521e0bc0bb3 [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/1e2/0nnhqo1xh8knvrj7ls0ul2nnz2f7kas0/r_pm_8.jpg [UNSAFE_SRC] => /upload/iblock/1e2/0nnhqo1xh8knvrj7ls0ul2nnz2f7kas0/r_pm_8.jpg [SAFE_SRC] => /upload/iblock/1e2/0nnhqo1xh8knvrj7ls0ul2nnz2f7kas0/r_pm_8.jpg [ALT] => Современные возможности управления метаболическим здоровьем у пациентов с ожирением и нарушениями углеводного обмена [TITLE] => Современные возможности управления метаболическим здоровьем у пациентов с ожирением и нарушениями углеводного обмена ) [~PREVIEW_PICTURE] => 1587 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => sovremennye-vozmozhnosti-upravleniya-metabolicheskim-zdorovem-u-patsientov-s-ozhireniem-i-narusheniya [~CODE] => sovremennye-vozmozhnosti-upravleniya-metabolicheskim-zdorovem-u-patsientov-s-ozhireniem-i-narusheniya [EXTERNAL_ID] => 1352 [~EXTERNAL_ID] => 1352 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 12 марта 2020 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия ожирения ) [VALUE_XML_ID] => Array ( [0] => obesity ) [VALUE_SORT] => Array ( [0] => 200 ) [VALUE] => Array ( [0] => Терапия ожирения ) [PROPERTY_VALUE_ID] => Array ( [0] => 114716 ) [VALUE_ENUM_ID] => Array ( [0] => 165 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия ожирения ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1588 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112287 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1588 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия ожирения ) [VALUE_XML_ID] => Array ( [0] => obesity ) [VALUE_SORT] => Array ( [0] => 200 ) [VALUE] => Array ( [0] => Терапия ожирения ) [PROPERTY_VALUE_ID] => Array ( [0] => 114716 ) [VALUE_ENUM_ID] => Array ( [0] => 165 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия ожирения ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия ожирения ) ) [IPROPERTY_VALUES] => Array ( ) ) [14] => Array ( [ID] => 1361 [~ID] => 1361 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Остеоартрит – аспекты фармакотерапии [~NAME] => Остеоартрит – аспекты фармакотерапии [ACTIVE_FROM_X] => 2018-12-02 00:00:00 [~ACTIVE_FROM_X] => 2018-12-02 00:00:00 [ACTIVE_FROM] => 02.12.2018 [~ACTIVE_FROM] => 02.12.2018 [TIMESTAMP_X] => 26.01.2022 12:07:49 [~TIMESTAMP_X] => 26.01.2022 12:07:49 [DETAIL_PAGE_URL] => /research/osteoartrit-aspekty-farmakoterapii/ [~DETAIL_PAGE_URL] => /research/osteoartrit-aspekty-farmakoterapii/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => В статье приведены данные сравнительных исследований нового отечественного «хондропротектора», активным компонентом
которого является биоактивный экстракт из мелкой морской рыбы, с препаратом алфлутоп. [~PREVIEW_TEXT] => В статье приведены данные сравнительных исследований нового отечественного «хондропротектора», активным компонентом которого является биоактивный экстракт из мелкой морской рыбы, с препаратом алфлутоп. [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [PREVIEW_PICTURE] => Array ( [ID] => 1603 [TIMESTAMP_X] => 26.01.2022 12:07:49 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 166689 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/2c9/0zkyvy9iw6c12zygvdook8edilkpmh4n [FILE_NAME] => r_pm)16.jpg [ORIGINAL_NAME] => r_pm)16.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 9631ede9f08c5fc6dd440ee36f362c93 [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/2c9/0zkyvy9iw6c12zygvdook8edilkpmh4n/r_pm%2916.jpg [UNSAFE_SRC] => /upload/iblock/2c9/0zkyvy9iw6c12zygvdook8edilkpmh4n/r_pm)16.jpg [SAFE_SRC] => /upload/iblock/2c9/0zkyvy9iw6c12zygvdook8edilkpmh4n/r_pm%2916.jpg [ALT] => Остеоартрит – аспекты фармакотерапии [TITLE] => Остеоартрит – аспекты фармакотерапии ) [~PREVIEW_PICTURE] => 1603 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => osteoartrit-aspekty-farmakoterapii [~CODE] => osteoartrit-aspekty-farmakoterapii [EXTERNAL_ID] => 1360 [~EXTERNAL_ID] => 1360 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 2 декабря 2018 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия остеоартроза ) [VALUE_XML_ID] => Array ( [0] => osteoarthritis ) [VALUE_SORT] => Array ( [0] => 500 ) [VALUE] => Array ( [0] => Терапия остеоартроза ) [PROPERTY_VALUE_ID] => Array ( [0] => 114717 ) [VALUE_ENUM_ID] => Array ( [0] => 167 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия остеоартроза ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1604 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112303 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1604 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия остеоартроза ) [VALUE_XML_ID] => Array ( [0] => osteoarthritis ) [VALUE_SORT] => Array ( [0] => 500 ) [VALUE] => Array ( [0] => Терапия остеоартроза ) [PROPERTY_VALUE_ID] => Array ( [0] => 114717 ) [VALUE_ENUM_ID] => Array ( [0] => 167 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия остеоартроза ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия остеоартроза ) ) [IPROPERTY_VALUES] => Array ( ) ) [15] => Array ( [ID] => 1359 [~ID] => 1359 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Остеоартрит в XXI веке: вызовы и решения [~NAME] => Остеоартрит в XXI веке: вызовы и решения [ACTIVE_FROM_X] => 2017-10-01 00:00:00 [~ACTIVE_FROM_X] => 2017-10-01 00:00:00 [ACTIVE_FROM] => 01.10.2017 [~ACTIVE_FROM] => 01.10.2017 [TIMESTAMP_X] => 26.01.2022 12:12:02 [~TIMESTAMP_X] => 26.01.2022 12:12:02 [DETAIL_PAGE_URL] => /research/osteoartrit-v-xxi-veke-vyzovy-i-resheniya/ [~DETAIL_PAGE_URL] => /research/osteoartrit-v-xxi-veke-vyzovy-i-resheniya/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Ввиду своей широкой распространенности, дегенеративно-дистрофические поражения суставов (остеоартроз/остеоартрит — ОА) представляют собой серьезную медико-социальную проблему во многих странах мира, включая Россию. Более того, показатели заболеваемости продолжают демонстрировать тенденцию к росту, в связи с чем особенно актуальным представляется поиск новых подходов к предотвращению прогрессирования данной группы заболеваний и методов наиболее эффективного лечения. [~PREVIEW_TEXT] => Ввиду своей широкой распространенности, дегенеративно-дистрофические поражения суставов (остеоартроз/остеоартрит — ОА) представляют собой серьезную медико-социальную проблему во многих странах мира, включая Россию. Более того, показатели заболеваемости продолжают демонстрировать тенденцию к росту, в связи с чем особенно актуальным представляется поиск новых подходов к предотвращению прогрессирования данной группы заболеваний и методов наиболее эффективного лечения. [PREVIEW_TEXT_TYPE] => html [~PREVIEW_TEXT_TYPE] => html [PREVIEW_PICTURE] => Array ( [ID] => 1599 [TIMESTAMP_X] => 26.01.2022 12:12:02 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 198560 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/081/zuav4tje2rcamrsbgyprh1rh9lx1ao1k [FILE_NAME] => r_pm_14.jpg [ORIGINAL_NAME] => r_pm_14.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 46b7f45eafbc220d1f961c33161630ab [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/081/zuav4tje2rcamrsbgyprh1rh9lx1ao1k/r_pm_14.jpg [UNSAFE_SRC] => /upload/iblock/081/zuav4tje2rcamrsbgyprh1rh9lx1ao1k/r_pm_14.jpg [SAFE_SRC] => /upload/iblock/081/zuav4tje2rcamrsbgyprh1rh9lx1ao1k/r_pm_14.jpg [ALT] => Остеоартрит в XXI веке: вызовы и решения [TITLE] => Остеоартрит в XXI веке: вызовы и решения ) [~PREVIEW_PICTURE] => 1599 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => osteoartrit-v-xxi-veke-vyzovy-i-resheniya [~CODE] => osteoartrit-v-xxi-veke-vyzovy-i-resheniya [EXTERNAL_ID] => 1358 [~EXTERNAL_ID] => 1358 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 1 октября 2017 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия остеоартроза ) [VALUE_XML_ID] => Array ( [0] => osteoarthritis ) [VALUE_SORT] => Array ( [0] => 500 ) [VALUE] => Array ( [0] => Терапия остеоартроза ) [PROPERTY_VALUE_ID] => Array ( [0] => 114718 ) [VALUE_ENUM_ID] => Array ( [0] => 167 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия остеоартроза ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1600 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112299 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1600 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия остеоартроза ) [VALUE_XML_ID] => Array ( [0] => osteoarthritis ) [VALUE_SORT] => Array ( [0] => 500 ) [VALUE] => Array ( [0] => Терапия остеоартроза ) [PROPERTY_VALUE_ID] => Array ( [0] => 114718 ) [VALUE_ENUM_ID] => Array ( [0] => 167 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия остеоартроза ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия остеоартроза ) ) [IPROPERTY_VALUES] => Array ( ) ) [16] => Array ( [ID] => 1356 [~ID] => 1356 [IBLOCK_ID] => 33 [~IBLOCK_ID] => 33 [IBLOCK_SECTION_ID] => [~IBLOCK_SECTION_ID] => [NAME] => Стратегия управления ожирением: итоги Всероссийской наблюдательной программы «ПримаВера» [~NAME] => Стратегия управления ожирением: итоги Всероссийской наблюдательной программы «ПримаВера» [ACTIVE_FROM_X] => 2016-02-01 00:00:00 [~ACTIVE_FROM_X] => 2016-02-01 00:00:00 [ACTIVE_FROM] => 01.02.2016 [~ACTIVE_FROM] => 01.02.2016 [TIMESTAMP_X] => 25.01.2022 19:51:51 [~TIMESTAMP_X] => 25.01.2022 19:51:51 [DETAIL_PAGE_URL] => /research/strategiya-upravleniya-ozhireniem-itogi-vserossiyskoy-nablyudatelnoy-programmy-primavera/ [~DETAIL_PAGE_URL] => /research/strategiya-upravleniya-ozhireniem-itogi-vserossiyskoy-nablyudatelnoy-programmy-primavera/ [LIST_PAGE_URL] => /research/ [~LIST_PAGE_URL] => /research/ [DETAIL_TEXT] => [~DETAIL_TEXT] => [DETAIL_TEXT_TYPE] => text [~DETAIL_TEXT_TYPE] => text [PREVIEW_TEXT] => Оценка эффективности и безопасности применения препарата Редуксин® (сибутрамин+МКЦ) у пациентов с алиментарным ожирением и различными сопутствующими заболеваниями в рутинной клинической практике. Анализ результатов Всероссийской наблюдательной программы «ПримаВера». [~PREVIEW_TEXT] => Оценка эффективности и безопасности применения препарата Редуксин® (сибутрамин+МКЦ) у пациентов с алиментарным ожирением и различными сопутствующими заболеваниями в рутинной клинической практике. Анализ результатов Всероссийской наблюдательной программы «ПримаВера». [PREVIEW_TEXT_TYPE] => text [~PREVIEW_TEXT_TYPE] => text [PREVIEW_PICTURE] => Array ( [ID] => 1593 [TIMESTAMP_X] => 25.01.2022 19:51:51 [MODULE_ID] => iblock [HEIGHT] => 882 [WIDTH] => 1500 [FILE_SIZE] => 264771 [CONTENT_TYPE] => image/jpeg [SUBDIR] => iblock/d01/q7b4l9n7vvn4d2c6i9bwjxayoh85caol [FILE_NAME] => r_pm_11.jpg [ORIGINAL_NAME] => r_pm_11.jpg [DESCRIPTION] => [HANDLER_ID] => [EXTERNAL_ID] => 31f2377d0e3daa89c9ce8065ed279795 [VERSION_ORIGINAL_ID] => [META] => [SRC] => /upload/iblock/d01/q7b4l9n7vvn4d2c6i9bwjxayoh85caol/r_pm_11.jpg [UNSAFE_SRC] => /upload/iblock/d01/q7b4l9n7vvn4d2c6i9bwjxayoh85caol/r_pm_11.jpg [SAFE_SRC] => /upload/iblock/d01/q7b4l9n7vvn4d2c6i9bwjxayoh85caol/r_pm_11.jpg [ALT] => Стратегия управления ожирением: итоги Всероссийской наблюдательной программы «ПримаВера» [TITLE] => Стратегия управления ожирением: итоги Всероссийской наблюдательной программы «ПримаВера» ) [~PREVIEW_PICTURE] => 1593 [LANG_DIR] => / [~LANG_DIR] => / [CODE] => strategiya-upravleniya-ozhireniem-itogi-vserossiyskoy-nablyudatelnoy-programmy-primavera [~CODE] => strategiya-upravleniya-ozhireniem-itogi-vserossiyskoy-nablyudatelnoy-programmy-primavera [EXTERNAL_ID] => 1355 [~EXTERNAL_ID] => 1355 [IBLOCK_TYPE_ID] => informationLang [~IBLOCK_TYPE_ID] => informationLang [IBLOCK_CODE] => researchRU [~IBLOCK_CODE] => researchRU [IBLOCK_EXTERNAL_ID] => 33 [~IBLOCK_EXTERNAL_ID] => 33 [LID] => s1 [~LID] => s1 [EDIT_LINK] => [DELETE_LINK] => [DISPLAY_ACTIVE_FROM] => 1 февраля 2016 [FIELDS] => Array ( ) [PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия ожирения ) [VALUE_XML_ID] => Array ( [0] => obesity ) [VALUE_SORT] => Array ( [0] => 200 ) [VALUE] => Array ( [0] => Терапия ожирения ) [PROPERTY_VALUE_ID] => Array ( [0] => 112292 ) [VALUE_ENUM_ID] => Array ( [0] => 165 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия ожирения ) [~DESCRIPTION] => Array ( [0] => ) ) [LINK] => Array ( [ID] => 178 [IBLOCK_ID] => 33 [NAME] => Ссылка [ACTIVE] => Y [SORT] => 200 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => 188 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Ссылка [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => [PROPERTY_VALUE_ID] => [DESCRIPTION] => [~DESCRIPTION] => [~VALUE] => ) [FILES] => Array ( [ID] => 179 [IBLOCK_ID] => 33 [NAME] => Файлы [ACTIVE] => Y [SORT] => 900 [CODE] => FILES [DEFAULT_VALUE] => [PROPERTY_TYPE] => F [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 182 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => Y [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Файлы [~DEFAULT_VALUE] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [VALUE] => Array ( [0] => 1594 ) [PROPERTY_VALUE_ID] => Array ( [0] => 112293 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => 1594 ) [~DESCRIPTION] => Array ( [0] => ) ) ) [DISPLAY_PROPERTIES] => Array ( [SOURCE] => Array ( [ID] => 177 [IBLOCK_ID] => 33 [NAME] => Направление [ACTIVE] => Y [SORT] => 100 [CODE] => SOURCE [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => 177 [FILE_TYPE] => [MULTIPLE_CNT] => 5 [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [~NAME] => Направление [~DEFAULT_VALUE] => [VALUE_ENUM] => Array ( [0] => Терапия ожирения ) [VALUE_XML_ID] => Array ( [0] => obesity ) [VALUE_SORT] => Array ( [0] => 200 ) [VALUE] => Array ( [0] => Терапия ожирения ) [PROPERTY_VALUE_ID] => Array ( [0] => 112292 ) [VALUE_ENUM_ID] => Array ( [0] => 165 ) [DESCRIPTION] => Array ( [0] => ) [~VALUE] => Array ( [0] => Терапия ожирения ) [~DESCRIPTION] => Array ( [0] => ) [DISPLAY_VALUE] => Терапия ожирения ) ) [IPROPERTY_VALUES] => Array ( ) ) ) 1
Изучение клинико-патогенетических эффектов противовирусного препарата на основе фавипиравира у коморбидных пациентов с COVID-19 на амбулаторном этапе лечения
05 дек 2021
Терапия COVID-19
Изучение клинико-патогенетических эффектов противовирусного препарата на основе фавипиравира у коморбидных пациентов с COVID-19 на амбулаторном этапе лечения
Открытое проспективное сравнительное исследование эффективности применения препарата «Арепливир®» (фавипиравир) в дебюте COVID-19 у коморбидных пациентов
Экспертный совет: «Возможности этиотропной терапии респираторных инфекций, вызванных РНК-вирусами»
26 апр 2021
Терапия COVID-19
Экспертный совет: «Возможности этиотропной терапии респираторных инфекций, вызванных РНК-вирусами»
Под эгидой консорциума академического содружества по изучению коронавирусной инфекции состоялся экспертный совет и Российского научного медицинского общества терапевтов и, посвященный современным аспектам этиотропной терапии новой коронавирусной инфекции и других заболеваний, вызванных РНК-вирусами.
Боткинские чтения
24 апр 2021
Материалы конференций
Боткинские чтения
Сборник тезисов Всероссийского терапевтического конгресса с международным участием.
Лечение остеоартроза крупных и мелких суставов с использованием инъекционного хондропротектора комплексного действия
01 апр 2021
Терапия остеоартроза
Лечение остеоартроза крупных и мелких суставов с использованием инъекционного хондропротектора комплексного действия
В многоцентровом исследовании оценивали эффективность и переносимость инъекционного средства замедленного действия для терапии остеоартроза крупных и мелких суставов.
Медицинская реабилитация женщин с ожирением после родов
13 янв 2021
Терапия ожирения
Медицинская реабилитация женщин с ожирением после родов
Определение эффективности комплексной программы послеродовой реабилитации, проводимой в течение 12 месяцев у женщин с ожирением.
Особенности коронавирусной инфекции COVID-19 и возможности раннего начала этиотропной терапии. Результаты клинического применения
28 сен 2020
Терапия COVID-19
Особенности коронавирусной инфекции COVID-19 и возможности раннего начала этиотропной терапии. Результаты клинического применения
В статье представлены результаты клинического исследования эффективности и безопасности этиотропной терапии у пациентов, госпитализированных с новой коронавирусной инфекцией, вызванной вирусом SARS-CoV-2
Новые возможности направленной противовирусной терапии COVID-19: результаты многоцентрового клинического исследования эффективности и безопасности применения препарата Арепливир
02 сен 2020
Терапия COVID-19
Новые возможности направленной противовирусной терапии COVID-19: результаты многоцентрового клинического исследования эффективности и безопасности применения препарата Арепливир
Цель исследования – изучить эффективность и безопасность применения препарата фавипиравир (Арепливир) у больных COVID-19 по сравнению с рекомендованной стандартной терапией.
Эффективность этиотропной терапии новой коронавирусной инфекции препаратом Арепливир (фавипиравир) в зависимости от времени начала лечения (клиническое наблюдение)
02 сен 2020
Терапия COVID-19
Эффективность этиотропной терапии новой коронавирусной инфекции препаратом Арепливир (фавипиравир) в зависимости от времени начала лечения (клиническое наблюдение)
В статье описаны клинические наблюдения, демонстрирующие улучшение клинического статуса пациентов, на фоне применения препарата Арепливир (фавипиравир), блокирующего репликацию вируса и доказавшего свою эффективность, в том числе в контролируемых исследованиях.
COVID-19: набор симптомов или системная патология? Клиническая лекция
02 сен 2020
Терапия COVID-19
COVID-19: набор симптомов или системная патология? Клиническая лекция
Часть 2. Арепливир (фавипиравир) в терапии пациентов с коронавирусной инфекцией: предпосылки для назначения и первые результаты использования. В статье представлена информация о безопасности и клинической эффективности фавипиравира в лечении инфекционных заболеваний, вызванных РНК-вирусами, в частности COVID-19, а также возможности применения препарата Арепливир (фавипиравир) у пациентов с новой коронавирусной инфекцией.
Краткий отчет о результатах клинического исследования лекарственного препарата Арепливир
17 авг 2020
Терапия COVID-19
Краткий отчет о результатах клинического исследования лекарственного препарата Арепливир
Открытое рандомизированное многоцентровое сравнительное исследование эффективности и безопасности препарата АРЕПЛИВИР, таблетки, покрытые пленочной оболочкой (ООО «ПРОМОМЕД РУС», Россия) у пациентов, госпитализированных с COVID-19.
Преимущества долгосрочного управления метаболическим здоровьем у пациентов с ожирением и ранними нарушениями углеводного обмена
18 июн 2020
Терапия ожирения
Преимущества долгосрочного управления метаболическим здоровьем у пациентов с ожирением и ранними нарушениями углеводного обмена
В статье представлены результаты наблюдательного исследования, демонстрирующие преимущества терапии фиксированной комбинацией сибутрамина и метформина в течение 12 мес в достижении метаболического здоровья.
Роль дозированных, лечебных, физических нагрузок и медикаментозной терапии в лечении больных остеоартритом
01 мая 2020
Терапия остеоартроза
Роль дозированных, лечебных, физических нагрузок и медикаментозной терапии в лечении больных остеоартритом
Цель исследования — проанализировать безопасность и эффективность лечения остеоартрита суставов кистей комбинацией дозированных, физических, лечебных нагрузок с парентеральным введением отечественного аналога алфлутопа — АМБЕНЕ® Био (Ambene® Bio).
Взаимосвязь ожирения и артериальной гипертензии: как влияние на аппетит может снизить артериальное давление?
12 мар 2020
Терапия ожирения
Взаимосвязь ожирения и артериальной гипертензии: как влияние на аппетит может снизить артериальное давление?
В данной статье разобрана патогенетическая связь повышения артериального давления с ожирением, а также рассмотрено, как снижение массы тела влияет на изменение артериального давления, особенно в рамках медикаментозной коррекции избытка жировой ткани.
Современные возможности управления метаболическим здоровьем у пациентов с ожирением и нарушениями углеводного обмена
12 мар 2020
Терапия ожирения
Современные возможности управления метаболическим здоровьем у пациентов с ожирением и нарушениями углеводного обмена
Исследование по использованию комбинированных препаратов, позволяющих воздействовать на разные патогенетические триггеры развития полиморбидной патологии при ожирении.
Остеоартрит – аспекты фармакотерапии
02 дек 2018
Терапия остеоартроза
Остеоартрит – аспекты фармакотерапии
В статье приведены данные сравнительных исследований нового отечественного «хондропротектора», активным компонентом
которого является биоактивный экстракт из мелкой морской рыбы, с препаратом алфлутоп.
Остеоартрит в XXI веке: вызовы и решения
01 окт 2017
Терапия остеоартроза
Остеоартрит в XXI веке: вызовы и решения
Ввиду своей широкой распространенности, дегенеративно-дистрофические поражения суставов (остеоартроз/остеоартрит — ОА) представляют собой серьезную медико-социальную проблему во многих странах мира, включая Россию. Более того, показатели заболеваемости продолжают демонстрировать тенденцию к росту, в связи с чем особенно актуальным представляется поиск новых подходов к предотвращению прогрессирования данной группы заболеваний и методов наиболее эффективного лечения.
Стратегия управления ожирением: итоги Всероссийской наблюдательной программы «ПримаВера»
01 фев 2016
Терапия ожирения
Стратегия управления ожирением: итоги Всероссийской наблюдательной программы «ПримаВера»
Оценка эффективности и безопасности применения препарата Редуксин® (сибутрамин+МКЦ) у пациентов с алиментарным ожирением и различными сопутствующими заболеваниями в рутинной клинической практике. Анализ результатов Всероссийской наблюдательной программы «ПримаВера».